It promotes the conversion of eumelanin (dark pigment) to pheomelanin (lighter pigment), says Newson
Research Background In preclinical research settings, DSIP has been examined across laboratory models, often in the context of: Neuropeptide and hypothalamic signalling studies Sleep-wake cycle and circadian rhythm research models Stress-response and neuroendocrine pathway investigations Published research summaries and references can be accessed via public scientific databases such as PubMed
Moreover, comparing the oxidative-resistant abilities between BP@CeO x and MBC, the results indicated that BP@CeO x showed a higher ROS clearance ratio during the first 4-day co-incubation period via directly exposing amounts of active sites to consume ROS in the environment (Supplementary Fig
The FDA has flagged emideltide/DSIP in a compounding safety-risk context because of insufficient safety information and concerns involving peptide impurities and immunogenicity, while existing human studies are too small and short-term to reliably assess long-term adverse effects
"Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes." Frontiers in Bioengineering and Biotechnology
